US519941A
(en)
|
|
1894-05-15 |
|
Reversing mechanism for metal shaping and planing machines |
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
US4608337A
(en)
|
1980-11-07 |
1986-08-26 |
The Wistar Institute |
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4701409A
(en)
|
1984-11-15 |
1987-10-20 |
The Wistar Institute |
Detection of B-cell neoplasms
|
US4693975A
(en)
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5015568A
(en)
|
1986-07-09 |
1991-05-14 |
The Wistar Institute |
Diagnostic methods for detecting lymphomas in humans
|
US5202429A
(en)
|
1986-07-09 |
1993-04-13 |
The Wistar Institute |
DNA molecules having human BCL-2 gene sequences
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
DE68921918T2
(de)
|
1988-05-09 |
1995-09-07 |
Univ Temple |
Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
|
US5198338A
(en)
|
1989-05-31 |
1993-03-30 |
Temple University |
Molecular probing for human t-cell leukemia and lymphoma
|
US5149628A
(en)
|
1989-11-15 |
1992-09-22 |
Temple University |
Methods for detecting bcl-3 gene in human leukemias
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
US6040140A
(en)
|
1991-12-11 |
2000-03-21 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
WO1993012136A1
(en)
|
1991-12-11 |
1993-06-24 |
Thomas Jefferson University |
Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
|
US5633135A
(en)
|
1991-12-11 |
1997-05-27 |
Thomas Jefferson University |
Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
PT667920E
(pt)
|
1992-10-29 |
2003-06-30 |
Univ Jefferson |
Metodos de deteccao de micrometasteses do cancro da prostata
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US7175995B1
(en)
|
1994-10-27 |
2007-02-13 |
Thomas Jefferson University |
TCL-1 protein and related methods
|
US5985598A
(en)
|
1994-10-27 |
1999-11-16 |
Thomas Jefferson University |
TCL-1 gene and protein and related methods and compositions
|
US5695944A
(en)
|
1995-05-05 |
1997-12-09 |
Thomas Jefferson University |
Modulation of bcl-2 phosphorylation
|
US5567586A
(en)
|
1995-05-18 |
1996-10-22 |
Thomas Jefferson University |
Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
US5928884A
(en)
|
1996-02-09 |
1999-07-27 |
Croce; Carlo M. |
FHIT proteins and nucleic acids and methods based thereon
|
US5849902A
(en)
|
1996-09-26 |
1998-12-15 |
Oligos Etc. Inc. |
Three component chimeric antisense oligonucleotides
|
US6187536B1
(en)
|
1997-02-18 |
2001-02-13 |
Thomas Jefferson University |
Methods of identifying and detecting pancreatic cancer
|
AU6951098A
(en)
|
1997-04-04 |
1998-10-30 |
The Texas A & M University System |
Noninvasive detection of colonic biomarkers using fecal messenger rna
|
CO5080817A1
(es)
|
1997-10-21 |
2001-09-25 |
Cancer Res Campaign Tech Ltd |
Determinacion de anormalidades en el crecimiento celular
|
US6303323B1
(en)
|
1997-10-21 |
2001-10-16 |
Cancer Research Campaign Technology Limited |
Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
|
WO2000003685A2
(en)
|
1998-07-20 |
2000-01-27 |
Thomas Jefferson University |
Nitrilase homologs
|
US6255293B1
(en)
|
1998-07-24 |
2001-07-03 |
Yeda Research And Development Co., Ltd. |
Prevention of metastasis with 5-aza-2′-deoxycytidine
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
EP1165586A4
(en)
|
1999-03-15 |
2003-05-28 |
Univ Jefferson |
TCL-1B GENES AND PROTEINS AND RELATED METHODS AND METHODS
|
US7163801B2
(en)
|
1999-09-01 |
2007-01-16 |
The Burnham Institute |
Methods for determining the prognosis for cancer patients using tucan
|
US6891031B2
(en)
|
2000-02-18 |
2005-05-10 |
The Regents Of The University Of California |
Coordinate cytokine regulatory sequences
|
WO2001068666A1
(en)
|
2000-03-14 |
2001-09-20 |
Thomas Jefferson University |
Tcl1 enhances akt kinase activity and mediates its nuclear translocation
|
AU2001249622B2
(en)
|
2000-03-30 |
2007-06-07 |
Massachusetts Institute Of Technology |
RNA sequence-specific mediators of RNA interference
|
JP2004516002A
(ja)
|
2000-04-11 |
2004-06-03 |
トーマス・ジェファーソン・ユニバーシティー |
Fhit欠損マウスにおけるミュア−トール様症候群
|
US20020086331A1
(en)
|
2000-05-16 |
2002-07-04 |
Carlo Croce |
Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers
|
US7060811B2
(en)
|
2000-10-13 |
2006-06-13 |
Board Of Regents, The University Of Texas System |
WWOX: a tumor suppressor gene mutated in multiple cancers
|
US20020173478A1
(en)
|
2000-11-14 |
2002-11-21 |
The Trustees Of The University Of Pennsylvania |
Post-transcriptional gene silencing by RNAi in mammalian cells
|
US20040033502A1
(en)
|
2001-03-28 |
2004-02-19 |
Amanda Williams |
Gene expression profiles in esophageal tissue
|
US20050176025A1
(en)
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
|
EP2385123B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
US7371736B2
(en)
*
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
US7455995B2
(en)
|
2001-11-09 |
2008-11-25 |
The Ohio State University Research Foundation |
BAALC expression as a diagnostic marker for acute leukemia
|
GB0128898D0
(en)
|
2001-12-03 |
2002-01-23 |
Biotech Res Ventures Pte Ltd |
Materials and methods relating to the stabilization and activation of a tumour suppressor protein
|
WO2003069853A1
(en)
|
2002-02-12 |
2003-08-21 |
Nokia Corporation |
Method for controlling data transmission, and data transmission system
|
JP2005517452A
(ja)
|
2002-02-20 |
2005-06-16 |
サーナ・セラピューティクス・インコーポレイテッド |
短干渉核酸(siNA)を用いるBCL2遺伝子発現のRNA干渉媒介性阻害
|
AU2003224672B2
(en)
|
2002-03-08 |
2010-02-04 |
Eisai R&D Management Co., Ltd. |
Macrocyclic compounds useful as pharmaceuticals
|
EP1496928A4
(en)
|
2002-04-08 |
2005-08-10 |
Ciphergen Biosystems Inc |
SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA
|
ATE446675T1
(de)
|
2002-04-29 |
2009-11-15 |
Univ Jefferson |
Humane chronische lymphozytische leukämie im mausmodell durch gezielte expression von tcl1
|
US7217568B2
(en)
|
2002-05-31 |
2007-05-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of identifying and isolating stem cells and cancer stem cells
|
US8119610B2
(en)
|
2002-05-31 |
2012-02-21 |
The Regents Of The University Of California |
Method for efficient RNA interference in mammalian cells
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
US20050260639A1
(en)
|
2002-09-30 |
2005-11-24 |
Oncotherapy Science, Inc. |
Method for diagnosing pancreatic cancer
|
AU2003284083A1
(en)
|
2002-10-11 |
2004-05-04 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
US20050266443A1
(en)
|
2002-10-11 |
2005-12-01 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
WO2004043387A2
(en)
|
2002-11-13 |
2004-05-27 |
Thomas Jefferson University |
Compositions and methods for cancer diagnosis and therapy
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
WO2004071464A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
WO2004079013A1
(en)
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
|
US7183384B2
(en)
|
2003-03-06 |
2007-02-27 |
A & G Pharmaceutical, Inc. |
Monoclonal antibody 7H11 reactive with human cancer
|
WO2004098377A2
(en)
|
2003-05-02 |
2004-11-18 |
Thomas Jefferson University |
Methods and compositions for diagnosis and therapy of parkin-associated disorders
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
DE602004018927D1
(de)
|
2003-06-18 |
2009-02-26 |
Genelux Corp |
Modifizierte rekombinante vacciniaviren, verwendungen davon
|
US7683036B2
(en)
*
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
WO2005047505A2
(en)
|
2003-08-07 |
2005-05-26 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro rnas
|
US20050037362A1
(en)
|
2003-08-11 |
2005-02-17 |
Eppendorf Array Technologies, S.A. |
Detection and quantification of siRNA on microarrays
|
US8412541B2
(en)
|
2003-08-14 |
2013-04-02 |
Edda Technology, Inc. |
Method and system for intelligent qualitative and quantitative analysis for medical diagnosis
|
US20050084883A1
(en)
|
2003-08-25 |
2005-04-21 |
The Johns Hopkins University School Of Medicine |
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
|
CA2539651A1
(en)
|
2003-09-22 |
2005-04-07 |
Rosetta Inpharmatics Llc |
Synthetic lethal screen using rna interference
|
WO2005028648A1
(ja)
|
2003-09-22 |
2005-03-31 |
Aichi Prefecture |
リンパ腫の病型および予後診断方法
|
CN1890382A
(zh)
|
2003-09-24 |
2007-01-03 |
肿瘤疗法科学股份有限公司 |
检测、诊断和治疗肝细胞癌(hcc)的方法
|
US20050186589A1
(en)
|
2003-11-07 |
2005-08-25 |
University Of Massachusetts |
Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi
|
US20050164252A1
(en)
|
2003-12-04 |
2005-07-28 |
Yeung Wah Hin A. |
Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
|
AU2004305075A1
(en)
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
JP4120002B2
(ja)
|
2004-01-07 |
2008-07-16 |
愛知県 |
miRNAを用いた癌の予後判定方法、癌の遺伝子治療ベクター及び癌治療用医薬組成物
|
EP2295604B1
(en)
|
2004-02-09 |
2015-04-08 |
Thomas Jefferson University |
Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
|
US20050256072A1
(en)
|
2004-02-09 |
2005-11-17 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
AU2005214904B2
(en)
|
2004-02-13 |
2011-07-21 |
Rockefeller University |
Anti-microRNA oligonucleotide molecules
|
JP4980878B2
(ja)
|
2004-02-23 |
2012-07-18 |
エラスムス ユニバーシティ メディカル センター ロッテルダム |
遺伝子発現プロファイリングによる急性骨髄性白血病の分類、診断、および予後
|
WO2005094263A2
(en)
|
2004-03-23 |
2005-10-13 |
Pintex Pharmaceuticals, Inc. |
Methods of determining the prognosis and treatment of subjects with colon cancer
|
US20060134639A1
(en)
|
2004-04-06 |
2006-06-22 |
Huffel Christophe V |
Method for the determination of cellular transcriptional regulation
|
US7365058B2
(en)
|
2004-04-13 |
2008-04-29 |
The Rockefeller University |
MicroRNA and methods for inhibiting same
|
KR20070004957A
(ko)
|
2004-04-20 |
2007-01-09 |
제나코 바이오메디컬 프로덕츠, 인코포레이티드 |
ncRNA 검출 방법
|
IL179285A
(en)
|
2004-05-14 |
2011-04-28 |
Rosetta Genomics Ltd |
Micrornas and uses thereof
|
JP2007536935A
(ja)
*
|
2004-05-14 |
2007-12-20 |
ベクトン・ディキンソン・アンド・カンパニー |
間葉幹細胞の無血清増殖のための細胞培養環境
|
EP2471922A1
(en)
*
|
2004-05-28 |
2012-07-04 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
US7635563B2
(en)
*
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
EP1773381A4
(en)
|
2004-07-01 |
2008-07-02 |
Univ Pittburgh Of The Commonwe |
EXOSOMES IMMUNOSUPPRESSANTS
|
US20060037088A1
(en)
|
2004-08-13 |
2006-02-16 |
Shulin Li |
Gene expression levels as predictors of chemoradiation response of cancer
|
JP2008511678A
(ja)
|
2004-09-02 |
2008-04-17 |
イェール ユニバーシティ |
マイクロrnaによるオンコジーンの調節
|
US7642348B2
(en)
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
FR2877350B1
(fr)
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
US8173611B2
(en)
*
|
2004-11-12 |
2012-05-08 |
Asuragen Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
WO2008073922A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Functions and targets of let-7 micro rnas
|
EP1662259A1
(en)
|
2004-11-25 |
2006-05-31 |
Cellzome Ag |
Use of Eph receptor inhibitors for the treatment of neurodegenerative diseases
|
EP1824872B1
(en)
|
2004-12-14 |
2012-02-08 |
Alnylam Pharmaceuticals Inc. |
Rnai modulation of mll-af4 and uses thereof
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
EP1959012A3
(en)
|
2004-12-29 |
2009-12-30 |
Exiqon A/S |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAs and their target mRNAs
|
CA2595716A1
(en)
|
2005-01-25 |
2006-08-03 |
Rosetta Inpharmatics Llc |
Methods for quantitating small rna molecules
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
CA2597767A1
(en)
|
2005-02-11 |
2006-08-17 |
Wisconsin Alumni Research Foundation |
Mir-155 assay
|
US20070065840A1
(en)
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
GB2425311A
(en)
|
2005-04-15 |
2006-10-25 |
Ist Superiore Sanita |
Micro RNA against kit protein
|
EP2631293A3
(en)
|
2005-04-29 |
2013-11-20 |
The Rockefeller University |
Human microRNAs and methods for inhibiting same
|
WO2006133022A2
(en)
|
2005-06-03 |
2006-12-14 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
US20070065844A1
(en)
|
2005-06-08 |
2007-03-22 |
Massachusetts Institute Of Technology |
Solution-based methods for RNA expression profiling
|
US20060292616A1
(en)
|
2005-06-23 |
2006-12-28 |
U.S. Genomics, Inc. |
Single molecule miRNA-based disease diagnostic methods
|
CA2617581A1
(en)
|
2005-08-01 |
2007-02-08 |
The Ohio State University Research Foundation |
Microrna-based methods for the diagnosis of breast cancer
|
US20070123482A1
(en)
|
2005-08-10 |
2007-05-31 |
Markus Stoffel |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
EP1937280B1
(en)
|
2005-09-12 |
2014-08-27 |
The Ohio State University Research Foundation |
Compositions for the therapy of bcl2-associated cancers
|
CA2624531A1
(en)
|
2005-10-05 |
2007-04-19 |
Carlo M. Croce |
Wwox gene, vectors containing the same, and uses in treatment of cancer
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
US7390792B2
(en)
|
2005-12-15 |
2008-06-24 |
Board Of Regents, The University Of Texas System |
MicroRNA1 therapies
|
AU2007205257B2
(en)
|
2006-01-05 |
2013-07-25 |
The Ohio State University Research Foundation |
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors
|
EP2468899B1
(en)
|
2006-01-05 |
2015-03-11 |
The Ohio State University Research Foundation |
MicroRNA-based methods for the diagnosis of stomach cancers
|
CN102943108B
(zh)
|
2006-01-05 |
2014-05-21 |
俄亥俄州立大学研究基金会 |
用于肺癌的诊断、预后和治疗的基于微小rna的方法和组合物
|
WO2007084486A2
(en)
|
2006-01-13 |
2007-07-26 |
Battelle Memorial Institute |
Animal model for assessing copd-related diseases
|
AU2007227423B2
(en)
|
2006-03-20 |
2013-11-07 |
The Ohio State University Research Foundation |
MicroRNA fingerprints during human megakaryocytopoiesis
|
US20090324618A1
(en)
|
2006-03-24 |
2009-12-31 |
Armstrong Scott A |
Novel signature self renewal gene expression programs
|
WO2007112754A2
(en)
|
2006-04-03 |
2007-10-11 |
Santaris Pharma A/S |
Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides
|
JP5127821B2
(ja)
|
2006-04-24 |
2013-01-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
miR155トランスジェニックマウスにおけるプレB細胞増殖及びリンパ芽球性白血病/高悪性度リンパ腫
|
AU2007293187A1
(en)
|
2006-06-30 |
2008-03-13 |
Rosetta Genomics Ltd |
A method for detecting nucleic acids
|
EP2369017B8
(en)
|
2006-07-13 |
2014-03-12 |
The Ohio State University Research Foundation |
Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases
|
CA2661354C
(en)
|
2006-08-30 |
2012-12-18 |
The Regents Of The University Of Michigan |
New small molecule inhibitors of mdm2 and the uses thereof
|
US20080193943A1
(en)
|
2006-09-05 |
2008-08-14 |
Abbott Laboratories |
Companion diagnostic assays for cancer therapy
|
CN101535505A
(zh)
|
2006-09-19 |
2009-09-16 |
俄亥俄州立大学研究基金会 |
慢性淋巴细胞性白血病(CLL)中受miR-29和miR-181调控的TCL1的表达
|
EP2076599A2
(en)
|
2006-09-19 |
2009-07-08 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
EP2115138A2
(en)
|
2006-09-19 |
2009-11-11 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
CA2663962A1
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
JP2008086201A
(ja)
|
2006-09-29 |
2008-04-17 |
Gifu Prefecture Kenkyu Kaihatsu Zaidan |
マイクロrna生成の検出方法と癌の診断・治療およびマイクロrna生成調整剤
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
CN101316935B
(zh)
|
2006-11-28 |
2012-02-29 |
博奥生物有限公司 |
一种用于诊断食道癌的芯片
|
US8293684B2
(en)
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
US20090092974A1
(en)
|
2006-12-08 |
2009-04-09 |
Asuragen, Inc. |
Micrornas differentially expressed in leukemia and uses thereof
|
AU2007333106A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-20 regulated genes and pathways as targets for therapeutic intervention
|
AU2007333107A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-21 regulated genes and pathways as targets for therapeutic intervention
|
CA2671270A1
(en)
|
2006-12-29 |
2008-07-17 |
Asuragen, Inc. |
Mir-16 regulated genes and pathways as targets for therapeutic intervention
|
CN103555825B
(zh)
|
2007-01-31 |
2015-09-30 |
俄亥俄州立大学研究基金会 |
用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物
|
US8765702B2
(en)
|
2007-02-27 |
2014-07-01 |
Rosetta Genomics Ltd. |
Composition and methods for modulating cell proliferation and cell death
|
WO2008113758A1
(en)
|
2007-03-16 |
2008-09-25 |
Covalx Ag |
Direct mass spectrometric analysis of drug candidates targeting protein complexes
|
TWI367949B
(en)
|
2007-04-10 |
2012-07-11 |
Univ Nat Taiwan |
Predicting post-treatment survival in cancer patients with microrn
|
EP2610347B1
(en)
|
2007-04-30 |
2015-04-15 |
The Ohio State University Research Foundation |
Methods of determining the prognosis of a subject with pancreatic cancer
|
US20090005336A1
(en)
|
2007-05-08 |
2009-01-01 |
Zhiguo Wang |
Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
|
US20090131354A1
(en)
|
2007-05-22 |
2009-05-21 |
Bader Andreas G |
miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
US20090232893A1
(en)
|
2007-05-22 |
2009-09-17 |
Bader Andreas G |
miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
US20090099034A1
(en)
|
2007-06-07 |
2009-04-16 |
Wisconsin Alumni Research Foundation |
Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
|
ES2537349T3
(es)
|
2007-06-08 |
2015-06-05 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para determinar un subtipo de carcinoma hepatocelular
|
JP2010529966A
(ja)
|
2007-06-08 |
2010-09-02 |
アシュラジェン インコーポレイテッド |
治療的介入の標的としてmiR−34によって調節される遺伝子および経路
|
EP2719773A3
(en)
|
2007-06-15 |
2014-07-30 |
The Ohio State University Research Foundation |
miRNA as marker for acute lamphomic leucemia
|
EP2613149B1
(en)
|
2007-07-25 |
2014-09-17 |
University Of Louisville Research Foundation, Inc. |
Exosome-associated microRNA as a diagnostic marker
|
WO2009018303A2
(en)
|
2007-07-31 |
2009-02-05 |
The Ohio State University Research Foundation |
Methods for reverting methylation by targeting dnmt3a and dnmt3b
|
CN103866008B
(zh)
|
2007-08-03 |
2016-06-29 |
俄亥俄州立大学研究基金会 |
编码ncrna的超保守区域
|
CA2696887C
(en)
|
2007-08-22 |
2016-06-28 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
US20090061424A1
(en)
|
2007-08-30 |
2009-03-05 |
Sigma-Aldrich Company |
Universal ligation array for analyzing gene expression or genomic variations
|
EP2775001B1
(en)
|
2007-09-06 |
2016-03-09 |
The Ohio State University Research Foundation |
MicroRNA signatures in human ovarian cancer
|
US20090239818A1
(en)
|
2007-09-07 |
2009-09-24 |
Cheng Jin Q |
Effective treatment of ovarian cancer using triciribine and related compounds
|
CA2699646A1
(en)
|
2007-09-14 |
2009-03-19 |
The Ohio State University Research Foundation |
Mirna expression in human peripheral blood microvesicles and uses thereof
|
US20100305188A1
(en)
|
2007-10-03 |
2010-12-02 |
Kyowa Hakko Kirin Co., Ltd. |
Nucleic acid capable of regulating the proliferation of cell
|
US8440637B2
(en)
|
2007-10-04 |
2013-05-14 |
Santaris Pharma A/S |
Combination treatment for the treatment of hepatitis C virus infection
|
US20100285471A1
(en)
|
2007-10-11 |
2010-11-11 |
The Ohio State University Research Foundation |
Methods and Compositions for the Diagnosis and Treatment of Esphageal Adenocarcinomas
|
AU2008316577B2
(en)
|
2007-10-26 |
2014-04-10 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
|
CN101980712B
(zh)
|
2007-10-29 |
2015-02-18 |
雷古拉斯治疗公司 |
用于肝癌治疗的靶向微小rna
|
US20090123933A1
(en)
|
2007-11-12 |
2009-05-14 |
Wake Forest University Health Sciences |
Microrna biomarkers in lupus
|
AU2008321253B2
(en)
|
2007-11-12 |
2014-01-16 |
Masaryk Memorial Cancer Institute |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
AU2008329755A1
(en)
|
2007-11-30 |
2009-06-04 |
The Ohio State University Research Foundation |
MicroRNA expression profiling and targeting in peripheral blood in lung cancer
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
WO2009086156A2
(en)
|
2007-12-21 |
2009-07-09 |
Asuragen, Inc. |
Mir-10 regulated genes and pathways as targets for therapeutic intervention
|
CN102084000B
(zh)
|
2008-02-01 |
2016-03-16 |
总医院有限公司 |
微泡在医学疾病和病况的诊断、预后以及治疗中的用途
|
US20090263803A1
(en)
|
2008-02-08 |
2009-10-22 |
Sylvie Beaudenon |
Mirnas differentially expressed in lymph nodes from cancer patients
|
WO2009108856A2
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
|
US20110034538A1
(en)
|
2008-02-28 |
2011-02-10 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer
|
CN104031984A
(zh)
|
2008-02-28 |
2014-09-10 |
俄亥俄州立大学研究基金会 |
用于前列腺相关病症的诊断、预后和治疗的基于微rna的方法和组合物
|
EP2250496A4
(en)
|
2008-02-28 |
2011-08-31 |
Univ Ohio State Res Found |
MICRO-RNA SIGNATURES ASSOCIATED WITH CYTOGENETICS AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF
|
EP2257626A2
(en)
|
2008-03-01 |
2010-12-08 |
Abraxis BioScience, LLC |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
WO2009111643A2
(en)
|
2008-03-06 |
2009-09-11 |
Asuragen, Inc. |
Microrna markers for recurrence of colorectal cancer
|
US20090253780A1
(en)
|
2008-03-26 |
2009-10-08 |
Fumitaka Takeshita |
COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
|
US20110166200A1
(en)
|
2008-04-24 |
2011-07-07 |
Zhan Zhang |
Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer
|
WO2009137807A2
(en)
|
2008-05-08 |
2009-11-12 |
Asuragen, Inc. |
Compositions and methods related to mirna modulation of neovascularization or angiogenesis
|
US20110107440A1
(en)
|
2008-06-04 |
2011-05-05 |
Andor Pivarcsi |
Skin cancer associated micrornas
|
WO2009149418A2
(en)
|
2008-06-06 |
2009-12-10 |
Asuragen, Inc. |
Novel compositions for the in vivo delivery of rnai agents
|
EP2307028B1
(en)
|
2008-06-11 |
2013-10-02 |
The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services |
Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
US20100021734A1
(en)
|
2008-07-22 |
2010-01-28 |
Covalent Materials Corporation |
Ceramic particles and producing method thereof
|
KR101031305B1
(ko)
|
2008-07-23 |
2011-04-29 |
국립암센터 |
마이크로rna-21 저해제를 포함하는 방사선 민감성증진용 조성물
|
US20110152357A1
(en)
|
2008-08-12 |
2011-06-23 |
The Ohio State University |
Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma
|
WO2010056737A2
(en)
|
2008-11-11 |
2010-05-20 |
Mirna Therapeutics, Inc. |
Methods and compositions involving mirnas in cancer stem cells
|
CA2744326A1
(en)
|
2008-11-21 |
2010-05-27 |
The Ohio State University Research Foundation |
Tcl1 as a transcriptional regulator
|
WO2010065156A1
(en)
|
2008-12-05 |
2010-06-10 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
|
WO2010099161A1
(en)
|
2009-02-26 |
2010-09-02 |
The Ohio State University Research Foundation |
Micrornas in never-smokers and related materials and methods
|
CA2715518A1
(en)
|
2009-09-23 |
2011-03-23 |
Wilson Roa |
Microrna expression profiles associated with lung cancer
|
US20120219958A1
(en)
|
2009-11-09 |
2012-08-30 |
Yale University |
MicroRNA Signatures Differentiating Uterine and Ovarian Papillary Serous Tumors
|
CN102803511A
(zh)
|
2009-11-23 |
2012-11-28 |
俄亥俄州立大学 |
用于影响肿瘤细胞生长、迁移和侵袭的材料和方法
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
CN103025384B
(zh)
|
2010-03-26 |
2016-04-20 |
俄亥俄州立大学 |
涉及miR-155对于错配修复和基因组稳定性的调节的材料和方法
|
EP2585822A4
(en)
|
2010-06-24 |
2014-03-12 |
|
BY TARGETED MIR-29 EXPRESSION IN A MOUSE MODELED CHRONIC LYMPHATIC LEUKEMIA
|
EP2600871A2
(en)
|
2010-08-04 |
2013-06-12 |
The Ohio State University |
Methods for impairing the p53/hdm2 auto-regulatory loop in multiple myeloma development using mir-192, mir-194 and mir-215
|
AU2011326032B2
(en)
|
2010-11-12 |
2016-10-06 |
The Ohio State University Research Foundation |
Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer
|
WO2012097047A1
(en)
|
2011-01-11 |
2012-07-19 |
The Ohio State University Research Foundation |
Methods to identify chronic lymphocytic leukemia disease progression
|
JP2014509852A
(ja)
|
2011-03-07 |
2014-04-24 |
ジ・オハイオ・ステート・ユニバーシティ |
マイクロRNA−155(miR−155)により誘導される変異誘発活性は炎症および癌を結び付ける
|